Cadila healthcare has informed that the company has enclosed a copy of press release dated March 4, 2020 titled ‘Zydus receives final approval from the USFDA for Emtricitabine and Tenofovir disoproxil Fumarate Tablets 200 mg / 300 mg’.
The above information is a part of company’s filings submitted to BSE.